{"id":"placebo-to-levocetirizine","safety":{"commonSideEffects":[{"rate":"1-2%","effect":"Somnolence"},{"rate":"2-3%","effect":"Headache"},{"rate":"1-2%","effect":"Fatigue"},{"rate":"1-2%","effect":"Dry mouth"}]},"_chembl":{"chemblId":"CHEMBL1201191","moleculeType":"Small molecule","molecularWeight":"388.90"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levocetirizine is the active enantiomer of cetirizine, a second-generation antihistamine that selectively antagonizes peripheral H1 receptors without significant central nervous system penetration. By blocking histamine binding at H1 receptors on mast cells and basophils, it prevents the cascade of allergic responses including itching, urticaria, and rhinitis symptoms. This study appears to be a placebo-controlled trial comparing levocetirizine efficacy.","oneSentence":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine signaling to reduce allergic symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:27.281Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Chronic urticaria"},{"name":"Allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT05637710","phase":"PHASE3","title":"Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-03","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT03545464","phase":"PHASE3","title":"COrticosteroids in acUte uRticAria in emerGency dEpartment","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-21","conditions":"Urticaria, Angiœdema","enrollment":137},{"nctId":"NCT04699604","phase":"PHASE3","title":"A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)","status":"RECRUITING","sponsor":"Bridgette Jones","startDate":"2021-04-28","conditions":"Allergic Asthma","enrollment":300},{"nctId":"NCT00359138","phase":"PHASE4","title":"The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypersensitivity","enrollment":36},{"nctId":"NCT01392859","phase":"PHASE2, PHASE3","title":"Characterization of the Role of Histamine in Children With Asthma","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2011-06","conditions":"Asthma, Allergic Asthma, Non-allergic Asthma","enrollment":211},{"nctId":"NCT03991845","phase":"PHASE4","title":"A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-06-21","conditions":"Urticaria, Vitamin D Deficiency","enrollment":262},{"nctId":"NCT00679250","phase":"PHASE4","title":"To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis","status":"COMPLETED","sponsor":"Brian J Lipworth","startDate":"2005-11","conditions":"Allergic Rhinitis","enrollment":25},{"nctId":"NCT00152464","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2002-03-20","conditions":"Dermatitis, Atopic","enrollment":514},{"nctId":"NCT02372604","phase":"PHASE3","title":"Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-07","conditions":"Chronic Spontaneous Urticaria","enrollment":15},{"nctId":"NCT00295022","phase":"PHASE4","title":"Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2006-07-29","conditions":"Rhinitis, Allergic, Seasonal","enrollment":418},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT02447393","phase":"PHASE1","title":"Phase 1 Study of Levocetirizine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-18","conditions":"Dermatitis","enrollment":20},{"nctId":"NCT00619801","phase":"PHASE3","title":"Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Allergic Rhinitis, Chronic Urticaria","enrollment":173},{"nctId":"NCT00628108","phase":"PHASE3","title":"Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Allergic Rhinitis, Chronic Urticaria","enrollment":69},{"nctId":"NCT00160563","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)","status":"TERMINATED","sponsor":"UCB Pharma","startDate":"2004-06","conditions":"Asthma","enrollment":207},{"nctId":"NCT00521170","phase":"PHASE1","title":"Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-11","conditions":"Allergy","enrollment":""},{"nctId":"NCT00315523","phase":"PHASE3","title":"Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-07","conditions":"Rhinitis, Allergic, Seasonal","enrollment":403},{"nctId":"NCT01496911","phase":"PHASE4","title":"Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving","status":"COMPLETED","sponsor":"Utrecht Institute for Pharmaceutical Sciences","startDate":"2012-04","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT00375713","phase":"PHASE3","title":"Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-10","conditions":"Dermatitis, Eczema","enrollment":466},{"nctId":"NCT00439712","phase":"PHASE4","title":"Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2007-02","conditions":"Perennial Allergic Rhinitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":118,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo to levocetirizine","genericName":"placebo to levocetirizine","companyName":"Brian J Lipworth","companyId":"brian-j-lipworth","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine signaling to reduce allergic symptoms. Used for Allergic rhinitis, Chronic urticaria, Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}